🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Phibro Animal Health Corporation

PAHC Healthcare
$35.93 +$0.62 (1.76%)
Market Cap: $1.46 B
Gurus Holding
3
Popularity Rank
#2807
% of Shares Held
1.45%
Net Activity (Q2 2026)
-$3.89 M

Guru Ownership Trend

Guru Analysis for Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Corporation (PAHC), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $21.08 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.89 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 11.7%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 16.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$211,009.44
Total Buy Value
New Buys 0
Additions 1
-$4.1 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Phibro Animal Health Corporation (PAHC)

Major holders include Renaissance Technologies (RenTech) ($15.09 M), Cliff Asness ($2.02 M), John Hussman ($1.32 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 586,738 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.89 M, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited PAHC. The total reported sell value was $4.1 M.

Yes, 0 managers opened new positions in PAHC, and 1 increased their existing holdings. The total reported buy value was $211,009.44.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% Reduce -16.7% 480,500 $15.09 M Q2 2026
0.00% Add 11.7% 64,238 $2.02 M Q2 2026
0.30% 42,000 $1.32 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form